How Integrating Addiction Care into Primary Clinics Transforms Treatment Access

By VirentaNews Staff — May 23, 2026

One in seven Americans will face a substance use disorder (SUD) in their lifetime, yet fewer than 20% receive treatment, according to the Substance Abuse and Mental Health Services Administration (SAMHSA). A recent initiative at the University of Cincinnati reveals a transformative solution: integrating addiction treatment directly into internal medicine resident clinics. Published in the journal Academic Medicine, the study found that embedding SUD services in primary care settings not only increased patient access to life-saving treatments like buprenorphine but also dramatically improved resident physicians’ confidence in managing addiction—a critical step toward closing the treatment gap. With opioid-related deaths surpassing 100,000 annually in the U.S., this model offers a scalable, sustainable pathway to address a national health crisis at the front lines of care.

A Model Born from Necessity

The integration of SUD treatment into primary care is not a new concept, but its implementation within teaching clinics has remained limited. The University of Cincinnati study emerged from a pressing need: despite the high prevalence of substance use disorders, most primary care physicians lack training and confidence in treating them. This treatment gap is especially acute in underserved communities, where access to specialized addiction services is often nonexistent. By embedding addiction specialists within internal medicine resident clinics, the program created a co-located care model that allowed trainees to learn evidence-based SUD treatment in real time, under supervision. The timing of this initiative aligns with broader national efforts to decentralize addiction care, reduce stigma, and treat SUDs as chronic medical conditions rather than moral failings. As healthcare systems grapple with rising overdose rates and fragmented care, this model offers a blueprint for systemic change grounded in medical education.

From Training to Transformation

The University of Cincinnati’s intervention involved restructuring workflows in its internal medicine resident continuity clinic to include addiction medicine specialists as core team members. Residents received hands-on training in screening, diagnosis, and treatment of SUDs, including prescribing medications like buprenorphine—a gold-standard therapy for opioid use disorder. Over a two-year period, the program led to a 300% increase in the number of patients receiving buprenorphine, with more than 150 patients initiated on treatment. Crucially, the study measured not just patient outcomes but also physician preparedness. Before the intervention, only 38% of residents reported feeling confident managing SUDs; after integration, that number soared to 89%. The program also established standardized protocols, peer support, and weekly case conferences, fostering a culture of shared learning and reduced stigma around addiction care.

Why Co-Location Works

The success of the Cincinnati model lies in its dual focus on patient access and physician education. Research has long shown that patients with SUDs are more likely to engage in treatment when services are integrated into primary care rather than siloed in specialty clinics. This co-location reduces logistical barriers, normalizes addiction treatment, and allows for holistic management of co-occurring conditions like hepatitis C, mental health disorders, and chronic pain. From a training perspective, learning addiction medicine in the context of ongoing patient relationships helps residents develop empathy and clinical competence. According to Dr. Sarah Wakeman, medical director of the Substance Use Disorder Initiative at Massachusetts General Hospital, who was not involved in the study, “Integrating SUD care into primary training programs is one of the most effective ways to build a workforce capable of addressing this epidemic”—a view echoed in a review published in JAMA Internal Medicine.

Implications for Health Equity

The implications of this model extend far beyond one academic medical center. By embedding addiction treatment in safety-net clinics where vulnerable populations seek care, the approach directly addresses disparities in SUD treatment access. Minority and low-income patients are less likely to receive medication for opioid use disorder, often due to a lack of providers and systemic bias. Training residents in integrated settings prepares a new generation of physicians to deliver equitable, trauma-informed care. Moreover, as more states expand Medicaid and incentivize value-based care, clinics that can treat both chronic medical conditions and SUDs will be better positioned to succeed. This model also aligns with recommendations from the National Academy of Medicine and the World Health Organization, both of which advocate for integrating addiction services into mainstream healthcare.

Expert Perspectives

While the Cincinnati study has been widely praised, some experts urge caution in scaling the model without adequate resources. “Integration sounds ideal, but it requires funding, staffing, and cultural change,” says Dr. Andrew Huhn, addiction psychiatrist at Johns Hopkins Medicine. Others highlight the importance of sustaining momentum beyond residency. “The real test is whether these physicians continue treating SUDs in practice,” notes Dr. Nora Volkow, director of the National Institute on Drug Abuse. Still, most agree that training in integrated settings is superior to standalone addiction rotations, which often fail to translate into routine clinical practice.

Looking ahead, researchers plan to track long-term patient outcomes and graduate practice patterns to assess sustainability. Key questions remain: Can this model be replicated in rural or resource-poor settings? Will policy changes support reimbursement for integrated care? As the U.S. continues to confront rising drug-related mortality, the answer may lie not in new medications or technologies, but in reimagining where and how care is delivered.

Source: MedicalXpress